2m 2m 2m 2m 2m 2m 2m
Verano Hldg (VRNO)
OTC
$5.13-$0.15 (-2.84%)
Price as of Oct 22, 2026- $375.6MMarket Cap
- N/A1-Year Change
- Drug Manufacturers - Specialty & GenericIndustry
Verano Hldg (VRNO)
$5.13-$0.15 (-2.84%)
Annual
Quarterly
12/31/2025 | 12/31/2024 | 12/31/2023 | 12/31/2022 | ||
|---|---|---|---|---|---|
Income Statement | |||||
Total Operating Revenue | 821.5M -6.50% | 878.6M -6.38% | 938.5M +6.71% | 879.4M N/A | |
Cost of Revenue | 408.0M -6.13% | 434.7M -6.17% | 463.2M +1.51% | 456.4M N/A | |
Gross Profit | 413.5M -6.86% | 443.9M -6.58% | 475.2M +12.33% | 423.1M N/A | |
Sales and Marketing Expense | 337.3M -4.55% | 353.4M +6.47% | 331.9M -6.91% | 356.6M N/A | |
Research and Development Expense | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Depreciation and Amortization Expense | 124.2M -11.10% | 139.7M -1.04% | 141.1M -0.18% | 141.4M N/A | |
Total Operating Expenses | 520.6M -23.57% | 681.1M +74.59% | 390.1M -33.40% | 585.8M N/A | |
Operating Profit | -107.1M -54.85% | -237.2M -379.74% | 84.8M +152.62% | -161.1M N/A | |
Interest Income | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Interest Expense | -53.6M -2.14% | -54.8M -8.42% | -59.8M +20.96% | -49.4M N/A | |
Interest Income and Expense and Net | -53.6M -2.14% | -54.8M -8.42% | -59.8M +20.96% | -49.4M N/A | |
Total Nonoperating Income and Expense | -59.1M -5.74% | -62.7M +10.10% | -57.0M +2,408.19% | -2.3M N/A | |
Income before Taxes | -166.2M -44.57% | -299.9M -1,178.91% | 27.8M +117.01% | -163.4M N/A | |
Income Taxes | 91.7M +118.57% | 41.9M -71.10% | 145.1M +37.62% | 105.5M N/A | |
Extraordinary Items | 183.3M -44.07% | 327.7M N/A | N/A N/A | N/A N/A | |
Net Income | -257.9M -24.56% | -341.9M +191.32% | -117.3M -56.40% | -269.2M N/A | |
Net Income from Continuing Operations Applicable to Common | -166.2M -44.57% | -299.9M -1,178.91% | 27.8M +117.01% | -163.4M N/A | |
Basic EPS and Net Income | -0.71 -27.55% | -0.98 +188.24% | -0.34 -58.02% | -0.81 N/A | |
Diluted EPS and Net Income | -0.71 -27.55% | -0.98 +188.24% | -0.34 -58.02% | -0.81 N/A | |
Basic Weighted Average Shares | 360.9M +3.24% | 349.6M +1.99% | 342.8M +3.43% | 331.4M N/A | |
Diluted Weighted Average Shares | 360.9M +3.24% | 349.6M +1.99% | 342.8M +3.43% | 331.4M N/A | |
Balance Sheet | |||||
Cash and Cash Equivalents | 82.7M -5.78% | 87.8M -49.76% | 174.8M +105.96% | 84.9M N/A | |
Short-Term Investments | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash and Cash Equivalents and Short-Term Investments | 82.7M -5.78% | 87.8M -49.76% | 174.8M +105.96% | 84.9M N/A | |
Total Current Assets | 404.7M +13.19% | 357.5M -9.31% | 394.2M +23.85% | 318.3M N/A | |
Accumulated Depreciation | 234.2M +28.23% | 182.6M +35.16% | 135.1M +52.62% | 88.5M N/A | |
Property and Plant and Equipment and Net | 492.5M -8.46% | 538.0M +7.31% | 501.3M -4.68% | 525.9M N/A | |
Total Long-Term Assets | 492.5M -8.46% | 538.0M +7.31% | 501.3M -4.68% | 525.9M N/A | |
Total Assets | 1.7B -12.44% | 2.0B -14.22% | 2.3B -3.23% | 2.4B N/A | |
Income Taxes Payable | 48.8M -63.30% | 132.9M -69.15% | 430.7M -4.13% | 449.2M N/A | |
Total Short-Term Debt | 7.9M -56.75% | 18.2M -65.09% | 52.0M +112.58% | 24.5M N/A | |
Total Current Liabilities | 140.3M -29.15% | 198.0M -51.97% | 412.2M +6.61% | 386.6M N/A | |
Total Long-Term Debt | 391.9M -0.96% | 395.7M +0.52% | 393.6M +1.31% | 388.5M N/A | |
Total Long-Term Liabilities | 899.0M +7.00% | 840.2M +26.06% | 666.5M -0.21% | 667.9M N/A | |
Total Liabilities | 1.0B +0.10% | 1.0B -3.76% | 1.1B +2.29% | 1.1B N/A | |
Retained Earnings | -1.0B N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Stockholders Equity | 704.2M -26.05% | 952.2M -23.22% | 1.2B -7.56% | 1.3B N/A | |
Total Shares Outstanding | 363.2M +1.25% | 358.7M +358,647.29% | 100,000 0.00% | 100,000 N/A | |
Cash Flow | |||||
Cash from Operating Activities | 52.9M -52.89% | 112.2M +2.27% | 109.7M +16.28% | 94.3M N/A | |
Capital Expenditures | 41.2M -58.38% | 99.0M +172.63% | 36.3M -69.52% | 119.2M N/A | |
Cash from Investing Activities | -32.6M -75.53% | -133.3M +181.12% | -47.4M -77.20% | -207.9M N/A | |
Dividends Paid | N/A N/A | N/A N/A | N/A N/A | 0 N/A | |
Cash from Financing Activities | -25.3M -61.59% | -65.9M -338.83% | 27.6M -72.19% | 99.2M N/A | |
Financials Ratio | |||||
Gross Margin | 50.33% -0.38% | 50.53% -0.22% | 50.64% N/A | N/A N/A | |
Operating Margin | -13.04% -51.71% | -27.00% -398.80% | 9.03% N/A | N/A N/A | |
Return on Assets | -13.83% -12.89% | -15.87% +218.85% | -4.98% N/A | N/A N/A | |
Return on Equity | -31.14% -0.15% | -31.19% +243.06% | -9.09% N/A | N/A N/A | |
Revenue Growth | -6.50% +1.84% | -6.38% -195.02% | 6.71% N/A | N/A N/A | |
Current Ratio | 2.89 +59.75% | 1.81 +88.82% | 0.96 N/A | N/A N/A | |
Cash Ratio | 0.59 +32.99% | 0.44 +4.60% | 0.42 N/A | N/A N/A | |
Debt-to-Equity Ratio | 0.57 +30.63% | 0.43 +20.92% | 0.36 N/A | N/A N/A | |
Debt-to-Assets Ratio | 0.23 +10.28% | 0.21 +8.27% | 0.19 N/A | N/A N/A | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow